BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 33513134)

  • 21. Update of transmission modelling and projections of gambiense human African trypanosomiasis in the Mandoul focus, Chad.
    Rock KS; Huang CI; Crump RE; Bessell PR; Brown PE; Tirados I; Solano P; Antillon M; Picado A; Mbainda S; Darnas J; Crowley EH; Torr SJ; Peka M
    Infect Dis Poverty; 2022 Jan; 11(1):11. PubMed ID: 35074016
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Integration of diagnosis and treatment of sleeping sickness in primary healthcare facilities in the Democratic Republic of the Congo.
    Mitashi P; Hasker E; Mbo F; Van Geertruyden JP; Kaswa M; Lumbala C; Boelaert M; Lutumba P
    Trop Med Int Health; 2015 Jan; 20(1):98-105. PubMed ID: 25329353
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Data-driven models to predict the elimination of sleeping sickness in former Equateur province of DRC.
    Rock KS; Pandey A; Ndeffo-Mbah ML; Atkins KE; Lumbala C; Galvani A; Keeling MJ
    Epidemics; 2017 Mar; 18():101-112. PubMed ID: 28279451
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trypanosome SL-RNA detection in blood and cerebrospinal fluid to demonstrate active gambiense human African trypanosomiasis infection.
    Ngay Lukusa I; Van Reet N; Mumba Ngoyi D; Miaka EM; Masumu J; Patient Pyana P; Mutombo W; Ngolo D; Kobo V; Akwaso F; Ilunga M; Kaninda L; Mutanda S; Muamba DM; Valverde Mordt O; Tarral A; Rembry S; Büscher P; Lejon V
    PLoS Negl Trop Dis; 2021 Sep; 15(9):e0009739. PubMed ID: 34534223
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modelling to explore the potential impact of asymptomatic human infections on transmission and dynamics of African sleeping sickness.
    Aliee M; Keeling MJ; Rock KS
    PLoS Comput Biol; 2021 Sep; 17(9):e1009367. PubMed ID: 34516544
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Distribution of infection by T. brucei gambiense in a population of Bandundu in the Republic of Zaire].
    Henry MC; Ruppol JF; Bruneel H
    Ann Soc Belg Med Trop; 1982 Dec; 62(4):301-13. PubMed ID: 7168586
    [No Abstract]   [Full Text] [Related]  

  • 27. [Importance of familial contamination in Trypanosoma brucei gambiense trypanosomiasis].
    Henry MC
    Bull Soc Pathol Exot Filiales; 1981; 74(1):65-71. PubMed ID: 7296731
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Review of the Situation of Human African Trypanosomiasis in the Republic of Congo From the 1950s to 2020.
    Bemba I; Bamou R; Lenga A; Okoko A; Awono-Ambene P; Antonio-Nkondjio C
    J Med Entomol; 2022 Mar; 59(2):421-429. PubMed ID: 35137146
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced passive screening and diagnosis for gambiense human African trypanosomiasis in north-western Uganda - Moving towards elimination.
    Wamboga C; Matovu E; Bessell PR; Picado A; Biéler S; Ndung'u JM
    PLoS One; 2017; 12(10):e0186429. PubMed ID: 29023573
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nifurtimox-eflornithine combination therapy for second-stage gambiense human African trypanosomiasis: Médecins Sans Frontières experience in the Democratic Republic of the Congo.
    Alirol E; Schrumpf D; Amici Heradi J; Riedel A; de Patoul C; Quere M; Chappuis F
    Clin Infect Dis; 2013 Jan; 56(2):195-203. PubMed ID: 23074318
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative evaluation of the strategy to eliminate human African trypanosomiasis in the Democratic Republic of Congo.
    Rock KS; Torr SJ; Lumbala C; Keeling MJ
    Parasit Vectors; 2015 Oct; 8():532. PubMed ID: 26490248
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost of a new method of active screening for human African trypanosomiasis in the Democratic Republic of the Congo.
    Snijders R; Fukinsia A; Claeys Y; Mpanya A; Hasker E; Meheus F; Miaka E; Boelaert M
    PLoS Negl Trop Dis; 2020 Dec; 14(12):e0008832. PubMed ID: 33315896
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trypanosoma brucei gambiense Type 1 populations from human patients are clonal and display geographical genetic differentiation.
    Morrison LJ; Tait A; McCormack G; Sweeney L; Black A; Truc P; Likeufack AC; Turner CM; MacLeod A
    Infect Genet Evol; 2008 Dec; 8(6):847-54. PubMed ID: 18790085
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of livestock density on Trypanosoma brucei gambiense and T. b. rhodesiense: A causal inference-based approach.
    Meisner J; Kato A; Lemerani MM; Mwamba Miaka E; Ismail Taban A; Wakefield J; Rowhani-Rahbar A; Pigott DM; Mayer JD; Rabinowitz PM
    PLoS Negl Trop Dis; 2022 Aug; 16(8):e0010155. PubMed ID: 36037205
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sensitivity and Specificity of a Prototype Rapid Diagnostic Test for the Detection of Trypanosoma brucei gambiense Infection: A Multi-centric Prospective Study.
    Bisser S; Lumbala C; Nguertoum E; Kande V; Flevaud L; Vatunga G; Boelaert M; Büscher P; Josenando T; Bessell PR; Biéler S; Ndung'u JM
    PLoS Negl Trop Dis; 2016 Apr; 10(4):e0004608. PubMed ID: 27058033
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predicting the Impact of Intervention Strategies for Sleeping Sickness in Two High-Endemicity Health Zones of the Democratic Republic of Congo.
    Rock KS; Torr SJ; Lumbala C; Keeling MJ
    PLoS Negl Trop Dis; 2017 Jan; 11(1):e0005162. PubMed ID: 28056016
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial.
    Priotto G; Kasparian S; Mutombo W; Ngouama D; Ghorashian S; Arnold U; Ghabri S; Baudin E; Buard V; Kazadi-Kyanza S; Ilunga M; Mutangala W; Pohlig G; Schmid C; Karunakara U; Torreele E; Kande V
    Lancet; 2009 Jul; 374(9683):56-64. PubMed ID: 19559476
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of passive case detection on the transmission dynamics of gambiense Human African Trypanosomiasis.
    Checchi F; Funk S; Chandramohan D; Chappuis F; Haydon DT
    PLoS Negl Trop Dis; 2018 Apr; 12(4):e0006276. PubMed ID: 29624584
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gambian human African trypanosomiasis in North West Uganda. Are we on course for the 2020 target?
    Selby R; Wamboga C; Erphas O; Mugenyi A; Jamonneau V; Waiswa C; Torr SJ; Lehane M
    PLoS Negl Trop Dis; 2019 Aug; 13(8):e0007550. PubMed ID: 31412035
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Health economic evaluation of strategies to eliminate gambiense human African trypanosomiasis in the Mandoul disease focus of Chad.
    Antillon M; Huang CI; Sutherland SA; Crump RE; Bessell PR; Shaw APM; Tirados I; Picado A; Biéler S; Brown PE; Solano P; Mbainda S; Darnas J; Wang-Steverding X; Crowley EH; Peka M; Tediosi F; Rock KS
    PLoS Negl Trop Dis; 2023 Jul; 17(7):e0011396. PubMed ID: 37498938
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.